Radiopharm Theranostics Ltd (RADX) Goodwill & Intangibles (2023 - 2025)

Radiopharm Theranostics (RADX) has reported Goodwill & Intangibles for 2 consecutive years, with $49.1 million the latest figure, recorded in Q2 2024.

• In Q2 2024, Goodwill & Intangibles fell 16.15% year-over-year to $49.1 million; the TTM figure through Jun 2024 stood at $49.1 million (down 16.15% YoY), while the FY2023 annual figure was $58.5 million, changed N/A from the prior year.
• Goodwill & Intangibles eased to $49.1 million in Q2 2024 per RADX's latest filing, from $58.5 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $58.5 million in Q2 2023 and bottomed at $49.1 million in Q2 2024.